Evidence map›Paper›PMID 41770595›Full record

ArticleMicrobiology (Reading, England)2026

Antifungal activity of the antimicrobial peptide RP557 against priority fungal pathogens.

Vanice Rodrigues Poester, Melissa Orzechowski Xavier, Jéssica Estefania Dávila Hidalgo, Mônica Campos Dos Santos, Mariana Rodrigues Trápaga, Abdullah M S Al-Hatmi, Jesse Jaynes, David A Stevens

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology (Reading, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vanice Rodrigues PoesterMycology Laboratory, Post-Graduate Program in Health Science, Faculty of Medicine, Federal University of Rio Grande, Rio Grande, Rio Grande do Sul, Brazil.
Melissa Orzechowski XavierMycology Laboratory, Post-Graduate Program in Health Science, Faculty of Medicine, Federal University of Rio Grande, Rio Grande, Rio Grande do Sul, Brazil.
Jéssica Estefania Dávila HidalgoMycology Laboratory, Post-Graduate Program in Health Science, Faculty of Medicine, Federal University of Rio Grande, Rio Grande, Rio Grande do Sul, Brazil.
Mônica Campos Dos SantosMycology Laboratory, Post-Graduate Program in Health Science, Faculty of Medicine, Federal University of Rio Grande, Rio Grande, Rio Grande do Sul, Brazil.
Mariana Rodrigues TrápagaMycology Laboratory, Post-Graduate Program in Health Science, Faculty of Medicine, Federal University of Rio Grande, Rio Grande, Rio Grande do Sul, Brazil.
Abdullah M S Al-HatmiNatural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.
Jesse JaynesColleges of Agriculture and Arts & Sciences, Tuskegee University, Tuskegee, Alabama, USA.
David A StevensDiv. of Infectious Diseases and Geographic Medicine, Stanford University Medical School, Stanford, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsAntimicrobial PeptidesFungiAnimalsCandidaCryptococcus neoformansHumansMicrobial Sensitivity TestsAntifungal AgentsAntimicrobial PeptidesAspergillus spp.Candida aurischromoblastomycosis and mycetoma speciesCryptococcus neoformansdermatophytesSporothrix spp.

Identifiers

PMID41770595
PMCPMC12952663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.